低剂量放疗增强大分割放疗联合抗PD1的远隔效应:小鼠与NSCLC患者研究
研究在小鼠双侧肿瘤模型和9例IV期非小细胞肺癌患者中评估大分割放疗(HFRT)、低剂量放疗(LDRT)与抗PD1三联治疗的远隔效应。小鼠中三联治疗优于各双联方案,过半小鼠完全治愈;患者中3例部分缓解、2例稳定,9个LDRT病灶中6个平均缩小28%。
要点
- 三联治疗在小鼠中增强远隔效应,过半完全治愈
- 患者中3例部分缓解、2例稳定,耐受良好
- 9个LDRT病灶中6个平均缩小28%
核心结论
- 临床前证明对已形成转移灶行LDRT可显著增强HFRT联合ICI的远隔效应。
- 额外LDRT在患者中耐受良好,该治疗模式有效且值得进一步研究。
研究设计与样本
- 研究采用双侧小鼠肿瘤模型及IV期非小细胞肺癌患者。
- 患者共9例接受HFRT、LDRT与抗PD1三联治疗。
主要发现
- 小鼠中三联治疗较HFRT/抗PD1、HFRT/LDRT或LDRT/抗PD1双联治疗增强远隔效应。
- 三联治疗小鼠中超过一半获得完全治愈。
- 远隔效应增强与CD8+效应T细胞浸润增加及T细胞趋化因子表达上调相关。
- 9例患者中3例部分缓解、2例疾病稳定。
- 9个较大LDRT病灶(175.7±42.3 cm3)中6个平均缩小28%。
临床怎么用
- 对已形成转移灶的非小细胞肺癌患者,可考虑在HFRT联合抗PD1基础上加用LDRT以增强远隔效应。
- LDRT在该三联方案中耐受良好,可作为候选联合策略进一步研究。
局限性
- 临床证据仅来自9例患者,样本量小。
- 原文未报告患者远隔效应的随机对照比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hypofractionated radiation therapy (HFRT) can induce antitumor T cell responses, particularly in combination with immune checkpoint inhibitors (ICI), but abscopal effects are often precluded by insufficient T cell infiltration of distant, nonirradiated tumors. Additional noncytotoxic, low-dose radiation therapy (LDRT) of distant tumors may enhance the abscopal response, but clinical evidence and preclinical studies for this scenario are lacking. METHODS AND MATERIALS: We investigated whether triple treatment consisting of HFRT, ICI, and LDRT could achieve better systemic antitumor response in bilateral mouse tumor models and in patients with stage IV non-small cell lung cancer. RESULTS: Our analyses of bilateral mouse tumor models show that HFRT treatment of the primary tumor combined with LDRT treatment of the abscopal tumor and anti-PD1 therapy enhances the abscopal response compared with HFRT/anti-PD1, HFRT/LDRT, or LDRT/anti-PD1 double treatments; complete cure was observed in more than half of the mice treated with triple therapy. The enhanced abscopal effect was associated with increased infiltration of CD8+ effector T cells and upregulated expression of T cell-attracting chemokines. Of 9 patients with metastatic non-small cell lung cancer who were treated with this triple therapy, 3 and 2 patients showed partial responses and stable disease, respectively. Among 9 relatively large (175.7 ± 42.3 cm3) LDRT lesions, 6 lesions decreased by 28% in size, on average. CONCLUSIONS: Our study demonstrates preclinically that LDRT of established metastases significantly enhances the abscopal response to HFRT plus ICI. It also shows that additional LDRT was well tolerated by patients and that this treatment profile is effective and worth further study.
引用
- Yin L, Xue J, Li R, et al. Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32417411. doi:10.1016/j.ijrobp.2020.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。